Procept Biorobotics
About Procept Biorobotics
PROCEPT BioRobotics is a commercial-stage surgical robotics company dedicated to advancing patient care through transformative solutions in urology. The company develops, manufactures, and sells the AquaBeam Robotic System and the HYDROS Robotic System. The AquaBeam Robotic System is an advanced, image-guided surgical robotic system used in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia (BPH).
The HYDROS Robotic System is particularly notable as an AI-powered robotic technology that delivers Aquablation therapy. Aquablation therapy integrates real-time, multidimensional imaging, personalized treatment planning, automated robotics, and heat-free waterjet ablation for targeted and rapid removal of prostate tissue. This innovative therapy is designed to provide effective, safe, and durable outcomes for males suffering from lower urinary tract symptoms (LUTS) due to BPH, independent of prostate size and shape or surgeon experience. Beyond BPH, PROCEPT BioRobotics is also actively exploring the potential of Aquablation therapy for localized prostate cancer treatment through ongoing clinical trials like the WATER IV PCa trial.
Focus Areas
Business Intelligence
| Key Investors | Fidelity Management & Research Company LLC, T. Rowe Price Associates, CPMG, Inc., Perceptive Advisors, Viking Global Investors LP, Duquesne Family Office, LLC, The Vanguard Group, BlackRock, AllianceBernstein, State Street Global Advisors |
| Partnerships | Providence (multi-system, national contract for AquaBeam Robotic Systems) |
| Technology | AQUABEAM Robotic System, HYDROS Robotic System, Aquablation therapy, real-time ultrasound imaging, AI-powered treatment planning (FirstAssist AI™), robotic resection, heat-free waterjet ablation |
| FDA Clearances | 2 cleared products (estimated) |
What Physicians Need to Know
For physicians, PROCEPT BioRobotics' Aquablation therapy offers predictable and reproducible outcomes due to its robotic precision and automated execution. The minimally invasive, heat-free approach significantly reduces the risk of sexual dysfunction and incontinence, which are major patient concerns, and is effective for all prostate sizes and shapes. The HYDROS system's streamlined workflow and AI-powered treatment planning enhance the surgeon's experience and efficiency. Physicians can rely on extensive clinical evidence, with over 150 peer-reviewed publications supporting the benefits of Aquablation therapy. Furthermore, the ongoing WATER IV trial for prostate cancer treatment presents a future opportunity to expand therapeutic options. PROCEPT BioRobotics also provides academic learning and workshops, along with reimbursement support, as Aquablation therapy has widespread insurance coverage.
The HYDROS Robotic System is designed with a single-footprint integrated tower to facilitate efficient operating room setup and turnover, suggesting a focus on seamless integration into existing surgical environments. Its AI-powered treatment planning (FirstAssist AIu2122) is built from a library of real-world Aquablation therapy procedures, indicating a system that learns and adapts from practical application. The system also integrates next-generation ultrasound imaging and digital cystoscopy for enhanced visualization, implying compatibility with advanced imaging modalities.
What the Web Says
Procept BioRobotics generally receives positive feedback for its innovative Aquablation product, which is considered life-changing for many patients with BPH due to its efficacy and preservation of sexual function. However, employee reviews indicate a mixed sentiment regarding the company culture and management, with some highlighting a fast-paced environment and great teams, while others point to poor management and a lack of work-life balance. The company is seen as growing rapidly within the medical device space.
Overall: MixedStrengths
- Aquablation product is innovative and life-changing for BPH patients.
- Aquablation offers superior preservation of sexual function compared to traditional procedures like TURP.
- The product has strong efficacy outcomes comparable to TURP with a superior safety profile.
- Good culture and great people are often mentioned by employees.
- Fast-growing company with a good trajectory.
- Dedicated reimbursement for their procedure and good outcome data.
Limitations
- Management is frequently cited as poor, indecisive, or toxic.
- Lack of work-life balance is a common complaint among employees.
- Benefits and pay are sometimes considered lacking.
- Some employees report a lack of support from managers and issues with trust in colleagues.
- High travel requirements for some positions, which may not be clearly communicated.
- Concerns about compensation for sales representatives.
Based on reviews from: Indeed.com, Aquablation Review | BPH Treatment, Procept Hydros robotics review by Steve Bell - YouTube, Reddit (r/MedicalDevices, r/ValueInvesting), A Narrative Review of Robotic Aquablation in Benign Prostatic Hyperplasia Care: Where We Are Now - PMC, AUA 2017: Procept BioRobotics' Aquablation Shows Superior Results vs. TURP in WATER Blinded Randomized Trial for BPH - UroToday, Aquablation of the prostate: a review and update - The Canadian Journal of Urology, Ladders
Last updated: 2026-07-19
Videos
News, demos, and interviews about Procept Biorobotics.
Videos load interactively. If none appear, search YouTube for Procept Biorobotics →
Press & Coverage
Frequently Asked Questions
Comparisons
Related Companies
QuickIntell is an AI-first healthcare technology company dedicated to transforming healthcare operations for physicians and healthcare providers. The company leverages advanced AI agents, including Computer Vision, Machine Learning, Optical Character Recognition (OCR), and Natural Language Processing (NLP), to streamline administrative workflows and enhance Revenue Cycle Management (RCM). QuickIntell’s solutions are designed to reduce administrative burden, […]
Ease Tax Relief, founded in 2016, is a tax relief and resolution company based in Harleysville, PA. The company specializes in helping individuals and small businesses resolve issues with the IRS, offering services such as Offer in Compromise, Partial Pay Installment Agreements, Payment Plans, and Penalty Reduction. Owned and operated by Zheng Yang, a CPA […]
CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]